D&D Pharmatech is a startup based in South Korea.
D&D Pharmatech develops innovative peptide-based therapeutics focusing on metabolic diseases, including GLP-1 class drugs for obesity and MASH treatment, and advances pipeline candidates via global clinical trials.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.